scispace - formally typeset
Open AccessJournal ArticleDOI

Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

Reads0
Chats0
TLDR
The results show how microbial lipids position the sugar for recognition by the invariant TCR and extend the range of microbes recognized by this conserved TCR to several clinically important bacteria.
Abstract
Natural killer T cells (NKT cells) recognize glycolipid antigens presented by CD1d. These cells express an evolutionarily conserved, invariant T cell antigen receptor (TCR), but the forces that drive TCR conservation have remained uncertain. Here we show that NKT cells recognized diacylglycerol-containing glycolipids from Streptococcus pneumoniae, the leading cause of community-acquired pneumonia, and group B Streptococcus, which causes neonatal sepsis and meningitis. Furthermore, CD1d-dependent responses by NKT cells were required for activation and host protection. The glycolipid response was dependent on vaccenic acid, which is present in low concentrations in mammalian cells. Our results show how microbial lipids position the sugar for recognition by the invariant TCR and, most notably, extend the range of microbes recognized by this conserved TCR to several clinically important bacteria.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Miscarriage induced by adoptive transfer of dendritic cells and invariant natural killer T cells into mice.

TL;DR: It is demonstrated that the adoptive transfer of DEC‐205+ bone marrow‐derived DCs cocultured with α‐GalCer directly induced marked fetal loss by syngeneic pregnant C57BL/6 (B6) mice and allogeneic mice and was accompanied by the accumulation of activated iNKT cells in the myometrium.
Journal ArticleDOI

Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?

TL;DR: The characteristics of NKT cells are summarized, an update is given about their role and the progress that has been made in the field of multiple myeloma (MM), and some challenges are discussed that are currently hampering further progress.
Journal ArticleDOI

Memory Follicular Helper Invariant NKT Cells Recognize Lipid Antigens on Memory B Cells and Elicit Antibody Recall Responses.

TL;DR: It is demonstrated that, in the absence of follicular helper T cells, cognate iNKT cell help could promote B cell memory responses in mice that were dependent on the formation of memory follicular helpers iN KT (iNKTFH) cells and their interactions with memory B cells in recall responses.
Journal ArticleDOI

Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.

TL;DR: The functions of CD1d-restricted iNKT cells in immune responses against microbial pathogens are summarized and the potential applications of glycolipid-mediated iN KT cell activation for preventing and controlling microbial infections are described.
References
More filters
Journal Article

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

TL;DR: Although universal screening for GBS colonization is anticipated to result in further reductions in the burden of GBS disease, the need to monitor for potential adverse consequences of intrapartum antibiotic use, such as emergence of bacterial antimicrobial resistance or increased incidence or severity of non-GBS neonatal pathogens, continues.
Journal ArticleDOI

Innate Immunity: The Virtues of a Nonclonal System of Recognition

TL;DR: Characterization of the nonclonal receptors of the innate immune system responsible for the adjuvant activity, and, evidently, for the associated side effects, would provide a powerful alternative approach, which would ultimately allow one to target these receptors directly.
Journal ArticleDOI

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

TL;DR: Glycosylceramide-mediated proliferative responses of Valpha14 NKT cells were abrogated by treatment with chloroquine-concanamycin A or by monoclonal antibodies against CD1d/Vbeta8, CD40/CD40L, or B7/CTLA-4/CD28, but not by interference with the function of a transporter-associated protein.
Journal ArticleDOI

The global burden of group A streptococcal diseases

TL;DR: The need to reinforce current control strategies, develop new primary prevention strategies, and collect better data from developing countries for most diseases is highlighted, as GAS is an important cause of morbidity and mortality.
Journal ArticleDOI

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

TL;DR: The burden of pneumococcal pneumonia is measured by applying the proportion of pneumonia cases caused by S pneumoniae derived from efficacy estimates from vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and deaths, using disease incidence and case-fatality data from a systematic literature review.
Related Papers (5)